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httpicense.Abstract Purpose: To evaluate dynamic multidetector CT (MDCT) in assessment of grades of
hepatocellular carcinoma (HCC).
Patients and methods: Forty patients of HCC were assessed. Enhancement patterns were correlated
with pathological grades.
Results: Three enhancement patterns were:1. Hyperattenuating lesions in portal venous phase.
2. Hypoattenuating lesions in all phases.
3. Hyperattenuating lesions in arterial phase.
Conclusion: Arterial and portal biphasic imaging was the most informative in assessment of tumor
grades. High grade lesions were hyperattenuating in arterial phase.
At initial evaluation, triphasic imaging is advisable, while in diagnosed cases and on follow up,
biphasic imaging could be satisfactory.
 2012 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Hepatocellular carcinoma (HCC) is the main primary liver
cancer and is considered as the third most common cause of
cancer mortality worldwide. The major risk factor for
hepatocellular carcinoma is chronic viral hepatitis, cirrhosis,.com
tian Society of Radiology and
g by Elsevier
Radiology and Nuclear Medicine.
://dx.doi.org/10.1016/j.ejrnm.2012consumption of alcohol and hemochromatosis. Males are
affected more than females and it is most common between
the ages of 30 and 50 years (1).
The prognosis of well differentiated HCCs is good follow-
ing resection or local therapy, while the prognosis of poorly
differentiated HCCs is poor due to greater tendency for vascu-
lar invasion and metastasis (2,3).
The rising incidence of hepatocellular carcinoma, combined
with decrease of available liver grafts has led to reﬁned selec-
tion criteria for liver transplantation candidates. Hence,
prognostic criteria of HCC include not only size and number
of tumor nodules, but also the presence of micro- and
macro-vascular invasions, satellite nodules, and grade of
differentiation (4).Production and hosting by Elsevier B.V.
.06.002
Fig. 1 Distribution of pathological grades and the three
enhancement patterns in this study. Hyperattenuating lesions in
arterial phases were seen in all tumor grades.
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according to the World Health Organization grading system:
grade I (well differentiated), grade II moderately differenti-
ated), grade III (poorly differentiated) and grade IV (undiffer-
entiated/anaplastic) (5).
Non-invasive diagnostic imaging has gained wide accep-
tance for the imaging of HCC with the assessment of tumor
vascularity (6).
There were only a limited number of studies that correlate
between dynamic MDCT and pathological tumor grades (7,8).
The purpose of this study was to evaluate the different
phases of dynamic MDCT in the assessment of different
grades of HCC.
2. Patients and methods
2.1. Study population
A retrospective study was conducted on 40 patients (18 fe-
males and 22 males with ages ranging from 39 years to78 -
years, mean age 61 years) with pathologically proven
hepatocellular carcinoma that underwent dynamic MDCT
studies at National Cancer Institute, Cairo University. Cases
with portal vein thrombosis were excluded from this study.
The histopathology was diagnosed by biopsy taken by needle
or from surgery.
No informed consent was taken since it was a retrospective
study, approved by institutional ethics committee.
2.2. Imaging methods and MDCT imaging protocol
CT studies were performed by using a 64 MDCT scanner
(Light speed 64-slice VCT, GE Healthcare, Milwaukee, WI,
USA) before and after IV contrast medium administration.
The precontrast series was taken by using a 5 mm slice
thickness.
The post-contrast study was done using about 120–180 ml
of low osmolar non-ionic contrast medium (iohexol, Omni-
paque 300; Amersham Health, Oslo, Norway) at a ﬂow rate
of 5 ml/s. The volume of contrast material was calculated
according to the body weight of the patient (2 mL of contrast
material per kilogram of body weight).
MDCT scan was performed with the following acquisition
parameters: 200 mAs, 120 kVp, 512 · 512 matrix, 1.1 pitch,
64 · 0.625 mm collimation, 2 mm slice thickness, 0.6 mm
reconstruction increment.
A quadruple phase protocol that included unenhanced, he-
patic arterial, portal venous and hepatic venous phases was
used.Table 1 The distribution of dynamic MDCT contrast enhancemen
Pathological grading of HCC Hyperattenuating
lesions in portal
venous phases
(Pattern 1)
H
le
p
(
Well diﬀerentiated 3 (7.5%) 8
Moderately diﬀerentiated 3 (7.5%) 2
Poorly diﬀerentiated 0 (0%) 0
Undiﬀerentiated 0 (0%) 0
Total 6 (15%) 1All patients received oral contrast material 1 h before CT
examination, followed by IV injection of nonionic contrast
medium using power injector.
The arterial phase, portal venous phase and hepatic venous
phase were taken at 20, 60 and 120 s, respectively, following IV
contrast injection. Automated bolus tracking with bolus detec-
tion at the level of the descending aorta above the diaphragm
ensured accurate timing of the data acquisition in arterial
phase.
2.3. Image analysis and interpretation
The HCC lesions were divided into 4 grades: grade 1 (well
differentiated), grade 2 (moderately differentiated), grade III
(poorly differentiated) and grade IV (undifferentiated/
anaplastic).
Different images were assessed for contrast enhancement
patterns in different phases and correlated with the patholog-
ical tumor grade.
Three phases (hepatic arterial, portal venous and hepatic
venous phases) of dynamic MDCT scan were studied and eval-
uated separately and in combination. The attenuations of
lesions in unenhanced scan and in the 3 phases of postcontrast
dynamic CT scan were analyzed, compared with surrounding
liver parenchyma and categorized as hyperattenution (or high
density), isoattenuation (or iso density) and hypoattenuation
(or low density) by visual inspection.
Arterial hypervascularity was deﬁned as hyperattenuation
of the lesion compared to liver parenchyma on the arterial
phase. Washout was deﬁned as increased lesion hypoattenua-t patterns according to pathological grades of HCC lesions.
ypoattenuating
sions in all
hases
Pattern 2)
Hyperattenuating
lesions in
arterial phases
(Pattern 3)
Total
(20%) 9 (22.5%) 20 (50%)
(5%) 3 (7.5%) 8 (20%)
(0%) 8 (20%) 8 (20%)
(0%) 4 (10%) 4 (10%)
0 (25%) 24 (60%) 40 (100%)
Fig. 3 Pathologically proved poorly differentiated HCC: 62 year old female with hyperattenuating lesion in left hepatic lobe seen in
portal venous phase (Pattern 1) of dynamic MDCT study (arrow). The lesion was isoattenuating to the liver parenchyma in the
precontrast study (A), hypoattenuating in the hepatic arterial phase (B), hyperattenuating in portal venous phase (C) and isoattenuating in
the hepatic venous phase (D). The patient also had bone deposit in dorsal vertebral body.
Fig. 2 Pathologically proved well differentiated HCC: 50 year old male with hyperattenuating lesion in left hepatic lobe seen in portal
venous phase (Pattern 1) of dynamic MDCT study (arrow). The lesion was isoattenuating to the liver parenchyma in the precontrast study
(A), hypoattenuating in the hepatic arterial phase (B), hyperattenuating in portal venous phase (C) and isoattenuating in the hepatic
venous phase (D).
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Fig. 4 Pathologically proved well differentiated HCC: 55 year old female with hypoattenuating lesion in anterior segment of right
hepatic lobe seen in all phases (Pattern 2) of dynamic MDCT study (arrow). The lesion was hypoattenuating to the liver parenchyma in the
precontrast study (A), hypoattenuating in the hepatic arterial, portal venous and hepatic venous phases (B), (C) and (D), respectively. The
patient also had ascites and splenic infarct.
Fig. 5 Pathologically proved moderately differentiated HCC: 65 year old female with hypoattenuating lesion in right hepatic lobe seen in
all phases (Pattern 2) of dynamic MDCT study (arrow). The lesion was hypoattenuating to the liver parenchyma in the precontrast study
(A), hypoattenuating in the hepatic arterial, portal venous and hepatic venous phases (B), (C) and (D), respectively.
364 A. Shokrytion on the venous phase compared to the arterial phase when
seen on standard liver windows.
Lesions were grouped based on enhancement into 3 enhance-
ment patterns:– Pattern 1 (hyperattenuating lesions in the portal venous
phase): High attenuation in the portal venous phase and
low attenuation in the hepatic arterial and hepatic venous
phases.
Fig. 6 Pathologically proved moderately differentiated HCC: 48 year old female with hyperattenuating lesion in lateral aspect of left
hepatic lobe seen in hepatic arterial phase (Pattern 3) of dynamic MDCT study (arrow). The lesion was isoattenuating to the liver
parenchyma in the precontrast study (A), hyperattenuating in the hepatic arterial phase (B), hypoattenuating in portal and hepatic venous
phases (C) and (D), respectively.
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attenuation in all phases.
– Pattern 3 (hyperattenuating lesions in arterial phase): High
attenuation in the hepatic arterial phase and low attenua-
tion in the portal venous and hepatic venous phases.
2.4. Comparison with histologic examination
The distribution of relative vascularity in different phases
(hyper, iso, or hypovascular pattern) was comparedwith the his-
tologic differentiation (well, moderately, poorly or undifferenti-
ated). Histologic grading was obtained retrospectively from the
pathologic reports given by pathologists.
2.5. Statistical analysis
Statistical calculations were performed using statistical soft-
ware (commercial computer program SPSS) with evaluation
of imaging patterns and pathological grades to identify signiﬁ-
cant relationships between radiological patterns and patholog-
ical grades. The level of statistical signiﬁcance was set at 0.05.
3. Results
Lesions of the study were pathologically classiﬁed as well
differentiated (20 cases = 50%), moderately differentiated (8cases = 20%), poorly differentiated (8 cases = 20%) and
undifferentiated (4 cases = 10%) HCC.
Regarding the enhancement pattern, lesions classiﬁed into
three patterns:
– Pattern 1: hyperattenuating in portal venous phase (6
patients = 15%).
– Pattern 2: hypoattenuating in all phases (10
patients = 25%).
– Pattern 3: hyperattenuating in arterial phase (24
patients = 60%).
The distribution of contrast enhancement patterns accord-
ing to tumor grade is shown in Table 1.
Cases of low grade (well and moderately differentiated)
HCC showed all patterns of enhancement. Cases of high grade
(poorly and undifferentiated) HCC showed only pattern 3 of
enhancement.
All patients with enhancement patterns 1 and 2 had low
grade (well and moderately differentiated) HCC, while
enhancement pattern 3 was seen in all tumor grades.
In the precontrast studies and in hepatic venous phases, all
lesions showed iso to hypoattenuation patterns and no patients
showed hyperattenuation pattern compared to the paren-
chyma in hepatic venous phases.
There was a signiﬁcant correlation between pathological
differentiation and enhancement patterns.
Fig. 7 Pathologically proved undifferentiated HCC: 70 year old male with hyperattenuating lesion in right hepatic lobe seen in hepatic
arterial phase (Pattern 3) of dynamic MDCT study (arrow). The lesion was isoattenuating to the liver parenchyma in the precontrast study
(A), hyperattenuating in the hepatic arterial phase with central nonenhanced hypodense areas of breaking down (B), hypoattenuating in
portal and hepatic venous phases (C) and (D), respectively.
366 A. Shokry(Fig. 1) showed the distribution of pathological grades and
the enhancement patterns in this study.
(Figs. 2–7) showed varieties of enhancement patterns of dif-
ferent tumor grades in this study.
4. Discussion
Hepatocellular carcinoma is a hypervascular neoplasm which
receives predominant blood supply from the hepatic artery,
resulting in relative enhancement of the lesion best seen on
arterial phase imaging. Arterial hypervascularity is an
important feature determining treatment options in HCC
(9).
The presence of washout kinetics is an indicator that the tu-
mor has higher intravascular space compared to interstitial
space (10,11). The role of contrast washout in portal phase
and delayed phase in characterization of hepatocellular carci-
noma regardless of lesion size has been established in previous
studies (12–14).
During hepatocarcinogenesis, ﬁrst arterial and then portal
blood ﬂow decreases. Because of the reduced arterial blood
ﬂow, the formation of new arterial vessels increases, and this
causes hypervascular lesions to occur. Therefore, the vascular-
ization degree of HCC is important for the prognosis and
treatment of the disease (7,15).
The ideal noninvasive imaging modality for the detection of
HCC is controversial. Advances in imaging modalities includ-
ing fast breath-hold MRI sequences and multidetector helical
CT technology now allow dynamic multiphasic enhanced
imaging of the liver with excellent resolution with improved tu-
mor detection (16–18).During hepatic dynamic CT, tumor vascularity and
blood supply of the liver play a greater role in determining
tumor-liver parenchyma contrast. During arterial phase, the
liver parenchyma is enhanced minimally because of the low
dependency on arterial blood supply, tumors are enhanced
to variable degrees according to their vascularity; hypervas-
cular tumors are enhanced maximally and show the greatest
contrast. On the other hand, hypovascular tumors are min-
imally enhanced because of poor arterial blood supply and
they are often isoattenuating and inconspicuous on arterial
phase images. During portal venous phase, the liver
parenchyma has peak enhancement because of the
enormous volume of portal venous blood supply to the li-
ver. Hypovascular tumors remain unenhanced or minimally
enhanced and are depicted as a hypoattenuating area
with the greatest contrast, whereas hypervascular tumors
often show increased attenuation similar to the attenuation
of enhanced liver parenchyma and decreased conspicuity
(19).
There were only a limited number of studies that correlate
between dynamic MDCT of HCC and pathological tumor
grades. Most of the previous studies have used invasive tech-
niques and focused mainly on early stages of HCC (7–9,20).
The purpose of this study was to evaluate the different
phases of noninvasive dynamic MDCT in the assessment of
different grades of HCC.
The results of this study showed that there is a signiﬁcant
relationship between pathological grades of HCC and
enhancement patterns.
Cases of low grade (well and moderately differentiated)
HCC showed all patterns of enhancement while cases of high
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3 of enhancement.
All patients with enhancement patterns 1 and 2 had low
grade (well and moderately differentiated) HCC while
enhancement pattern 3 was seen in all tumor grades. This pre-
sentation is attributable to greater arterial vascularization of
poorly and undifferentiated lesions and this could denote a late
pathological stage. These ﬁndings can be helpful in evaluation,
differentiation and characterization of lesions at initial diagno-
sis and on follow up as arterial hypervascularity is an impor-
tant feature in the assessment of HCC.
In this study, no patients showed hyperattenuation pat-
tern compared to liver parenchyma in the precontrast studies
or in the hepatic venous phases, so hepatic venous phase
imaging was not so informative regarding the assessment
of tumor grades. Hepatic venous phase imaging could be
more beneﬁcial in diagnostic performance for the detection
of small lesions of HCC, therefore, it is recommended to
add this phase at initial diagnosis to detect smaller lesions
that would be difﬁcult to detect using arterial and portal
venous phase imaging only. In addition, hyperattenuating
lesions in hepatic venous phase can suggest the diagnosis
of hemangioma (21).
There was a signiﬁcant correlation between pathological
differentiation and enhancement patterns in this study.
The observations in this study have been supported by pre-
vious reports and published studies (22,23).
Cases with portal vein thrombosis were excluded from this
study to avoid effects of portal thrombosis on hepatic and
lesion vascularity.
5. Conclusion
Biphasic imaging with combination of the arterial and portal
venous phases showed the most informative data in the assess-
ment of different grades of HCC. Hypoattenuating lesions in
arterial phase were seen in low grade (well and moderately dif-
ferentiated) HCC, while hyperattenuating lesions in arterial
phase were seen in all tumor grades.
All cases of high grade (poor and undifferentiated) HCC
showed hyperattenuating lesions in arterial phase, while cases
of low grade (well and moderately differentiated) HCC showed
all patterns of enhancement.
At initial evaluation of undiagnosed cases of HCC, tripha-
sic imaging is advisable, while in diagnosed, known cases and
on follow up, biphasic imaging could be satisfactory where, the
hepatic venous phase and precontrast scan can be omitted to
decrease scanning time and radiation hazards.References
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